Jose Escandell PhD

Jose Escandell is a Principal Scientist at iBET – Instituto de Biologia Experimental e Tecnológica, a leading non-profit research institution in biotechnology and bioprocess development based in Portugal. He specializes in advanced biopharmaceutical research, with a strong focus on gene therapy, viral vector production, and antibody engineering. His work contributes to improving scalable manufacturing strategies for complex biologics, particularly recombinant adeno-associated viruses (rAAVs), which are widely used in gene therapy applications.

At iBET, Escandell is actively involved in cutting-edge R&D projects and international scientific collaborations, presenting his research at major conferences and contributing to innovations in cell-based technologies and bioprocess optimization. His research supports the development of efficient, cost-effective biomanufacturing solutions, helping bridge the gap between academic science and industrial application in the rapidly evolving field of biotechnology.